Table 2.
Treatment | Phase | ClinicalTrials.gov identifier |
---|---|---|
HSV-1 M002 (IT or IV) | I | NCT00931931 |
HSV-1 M002 + concurrent radiation | I/II | NCT02453191 |
HSV-1 M002 + pembrolizumab | II | NCT03069378 |
TVEC + preoperative radiation | I/II | NCT02453191 |
JX-594 + cyclophosphamide | I/II | NCT02630368 |
TTI-621 | I | NCT02890368 |
INTUVAX | I | NCT02686944 |
Poly-ICLC | II | NCT01984892 |
Clostridium novyi-NT spores | I | NCT01924689 |